Found: 23
Select item for more details and to access through your institution.
Numerical Solution for Advection-Dispersion Equation with Uniform and Varying Boundary Conditions.
- Published in:
- Environmental & Earth Sciences Research Journal, 2022, v. 9, n. 4, p. 133, doi. 10.18280/eesrj.090401
- By:
- Publication type:
- Article
Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 2, p. 1, doi. 10.1177/2055217319850193
- By:
- Publication type:
- Article
The Relationship Between Mindfulness and Pain in Multiple Sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
A Randomized Pilot Study of Naturopathic Medicine in Multiple Sclerosis.
- Published in:
- Journal of Alternative & Complementary Medicine, 2008, v. 14, n. 5, p. 489, doi. 10.1089/acm.2007.0757
- By:
- Publication type:
- Article
Rituximab for treatment of refractory multiple sclerosis relapses during pregnancy.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 10, p. 1620, doi. 10.1177/1352458521998937
- By:
- Publication type:
- Article
Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: No.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 11, p. 1529, doi. 10.1177/1352458512462075
- By:
- Publication type:
- Article
Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling.
- Published in:
- PLoS ONE, 2010, v. 5, n. 9, p. 1, doi. 10.1371/journal.pone.0013058
- By:
- Publication type:
- Article
Correction to: Dietary Interventions and Multiple Sclerosis.
- Published in:
- Current Neurology & Neuroscience Reports, 2017, v. 17, n. 12, p. 1, doi. 10.1007/s11910-017-0804-4
- By:
- Publication type:
- Article
Dietary Interventions and Multiple Sclerosis.
- Published in:
- Current Neurology & Neuroscience Reports, 2017, v. 17, n. 3, p. 1, doi. 10.1007/s11910-017-0732-3
- By:
- Publication type:
- Article
Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.
- Published in:
- Current Neurology & Neuroscience Reports, 2016, v. 16, n. 11, p. 1, doi. 10.1007/s11910-016-0700-3
- By:
- Publication type:
- Article
New Disease-Modifying Therapies and New Challenges for MS.
- Published in:
- Current Neurology & Neuroscience Reports, 2012, v. 12, n. 5, p. 489, doi. 10.1007/s11910-012-0295-2
- By:
- Publication type:
- Article
Cognitive Impairment and MS: Searching for Effective Therapies.
- Published in:
- Current Neurology & Neuroscience Reports, 2011, v. 11, n. 5, p. 451, doi. 10.1007/s11910-011-0217-8
- By:
- Publication type:
- Article
Oral Disease-Modifying Therapies for Multiple Sclerosis: Are We There Yet?
- Published in:
- Current Neurology & Neuroscience Reports, 2010, v. 10, n. 5, p. 333, doi. 10.1007/s11910-010-0126-2
- By:
- Publication type:
- Article
Alemtuzumab versus interferon beta-1a in early multiple sclerosis.
- Published in:
- 2009
- By:
- Publication type:
- Report
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
- Published in:
- 2008
- By:
- Publication type:
- Report
Complementary and alternative medicine: Is there a role in multiple sclerosis?
- Published in:
- Current Neurology & Neuroscience Reports, 2006, v. 6, n. 3, p. 259, doi. 10.1007/s11910-006-0014-y
- By:
- Publication type:
- Article
Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters.
- Published in:
- Multiple Sclerosis (13524585), 2010, v. 16, n. 4, p. 387, doi. 10.1177/1352458509359722
- By:
- Publication type:
- Article
Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis.
- Published in:
- Immunology, 2008, v. 123, n. 1, p. 66, doi. 10.1111/j.1365-2567.2007.02703.x
- By:
- Publication type:
- Article
A low-fat diet improves fatigue in multiple sclerosis: Results from a randomized controlled trial.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 13, p. 1659, doi. 10.1177/13524585231208330
- By:
- Publication type:
- Article
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
- Published in:
- Autoimmune Diseases (2090-0422), 2012, p. 1, doi. 10.1155/2012/954739
- By:
- Publication type:
- Article
The Effects of Omega-3 Fatty Acids on Matrix Metalloproteinase-9 Production and Cell Migration in Human Immune Cells: Implications for Multiple Sclerosis.
- Published in:
- Autoimmune Diseases (2090-0422), 2011, p. 1, doi. 10.4061/2011/134592
- By:
- Publication type:
- Article
Lipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects.
- Published in:
- Molecular Neurobiology, 2018, v. 55, n. 7, p. 6037, doi. 10.1007/s12035-017-0813-y
- By:
- Publication type:
- Article